Aggressive B-Cell Non-Hodgkin Lymphoma

general

A B-cell non-Hodgkin lymphoma with an aggressive clinical course. This category includes B lymphoblastic lymphoma, subtypes of diffuse large B-cell lymphoma, Burkitt lymphoma, grade 3 follicular lymphoma, and mantle cell lymphoma.

50

Centers

35

Active Trials

$12.3B

Cancer Funding

Specific Cancer Types(5)

Top Centers for Aggressive B-Cell Non-Hodgkin Lymphoma(50)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
60.0
2
NCI Comprehensive
Active Research Program
60.0
3
NCI Comprehensive
Active Research Program
60.0
4
NCI Comprehensive
Active Research Program
60.0
5
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
60.0
6
NCI Comprehensive
7
NCI Comprehensive
8
NCI Comprehensive
9
NCI Comprehensive
10
NCI Comprehensive
11
NCI Comprehensive
12
NCI Comprehensive
13
NCI Comprehensive
14
15
NCI Comprehensive
16
17
18
19
20
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
21
NCI Comprehensive
22
NCI Comprehensive
23
NCI Comprehensive
24
NCI Comprehensive
25
NCI Comprehensive
26
NCI Comprehensive
27
28
NCI Clinical
29
NCI Comprehensive
30
31
Cedars-Sinai CancerLos Angeles, CA
32
NCI Comprehensive
33
34
35
36
NCI Comprehensive
37
38
39
40
41
NCI Comprehensive
42
43
44
45
46
47
48
49
50

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →